Zobrazeno 1 - 10
of 52
pro vyhledávání: '"John P. Middleton"'
Autor:
Sean D, Pokorney, Glenn M, Chertow, Hussein R, Al-Khalidi, Dianne, Gallup, Pat, Dignacco, Kurt, Mussina, Nisha, Bansal, Crystal A, Gadegbeku, David A, Garcia, Samira, Garonzik, Renato D, Lopes, Kenneth W, Mahaffey, Kelly, Matsuda, John P, Middleton, Jennifer A, Rymer, George H, Sands, Ravi, Thadhani, Kevin L, Thomas, Jeffrey B, Washam, Wolfgang C, Winkelmayer, Christopher B, Granger
Publikováno v:
Circulation. 146:1735-1745
Background: There are no randomized data evaluating the safety or efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial fibrillation (AF). Methods: The RENAL-AF trial (Renal Hemodialysis
Autor:
Dominic S. Raj, Rupal Mehta, Tamara Isakova, Joachim H. Ix, Kalani L. Raphael, Linda F. Fried, John P. Middleton, Roberto Sarnari, Alfred K. Cheung, Geoffrey A. Block, Anand Srivastava, Myles Wolf, Ann A. Wang, Jennifer J. Gassman, James C. Carr, Xuan Cai, Amir Ali Rahsepar, Stuart M. Sprague, Michel Chonchol, Pottumarthi V. Prasad
Publikováno v:
Kidney360
Background: Individuals with chronic kidney disease (CKD) have a high burden of cardiovascular disease (CVD). Abnormalities in cardiac structure and function represent subclinical CVD and can be assessed by cardiac magnetic resonance imaging (cMRI).
Autor:
Kalani L. Raphael, Michael F. Flessner, Brett Larive, John P. Middleton, Thomas H. Hostetter, Dominic S. Raj, Tamara Isakova, Susan R. Mendley, Linda F. Fried, Alfred K. Cheung, Stuart M. Sprague, Cynthia Kendrick, Geoffrey A. Block, Ping Li, Joachim H. Ix, Jennifer J. Gassman, Donald E. Wesson, Myles Wolf
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Oral sodium bicarbonate (NaHCO(3)) may preserve kidney function in CKD, even if initiated when serum bicarbonate concentration is normal. Adequately powered trials testing this hypothesis have not been conducted, partly because the best d
Publikováno v:
Advances in Chronic Kidney Disease. 25:454-467
Chronic diseases of the heart and of the kidneys commonly coexist in individuals. Certainly combined and persistent heart and kidney failure can arise from a common pathologic insult, for example, as a consequence of poorly controlled hypertension or
Autor:
Stepan M, Esagian, Georgios A, Sideris, Muath, Bishawi, Ioannis A, Ziogas, Ruediger W, Lehrich, John P, Middleton, Paul V, Suhocki, Theodore N, Pappas, Konstantinos P, Economopoulos
Publikováno v:
Journal of nephrology. 34(5)
No consensus currently exists regarding the optimal approach for peritoneal dialysis catheter placement. We aimed to compare the outcomes of percutaneous and surgical peritoneal dialysis catheter placement.A systematic review of the literature was pe
Autor:
John P. Middleton, Patrick H. Pun
Publikováno v:
Journal of the American Society of Nephrology. 28:3441-3451
One of the fundamental goals of the hemodialysis prescription is to maintain serum potassium levels within a narrow normal range during both the intradialytic and interdialytic intervals. Considering the extraordinarily high rate of cardiovascular mo
Publikováno v:
Seminars in Dialysis. 29:52-61
Patients with advanced chronic kidney disease (CKD), particularly those who have end-stage renal disease (ESRD) and require therapy with dialysis, suffer disproportionately from cardiovascular illnesses. Therapy with mineralocorticoid receptor antago
Autor:
Stephen C. Hammill, Gillian D Sanders, Anne S. Hellkamp, Gregg C. Fonarow, Patrick H. Pun, Lesley H. Curtis, Hussein R. Al-Khalidi, John P. Middleton, Sana M. Al-Khatib
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association-European Renal Association, vol 30, iss 5
Background. Sudden cardiac death is the leading cause of death among end-stage kidney disease patients (ESKD) on dialysis, but the benefit of primary prevention implantable cardioverter defibrillators (ICDs) in this population is uncertain. We conduc
Autor:
Uptal D. Patel, John P. Middleton
Publikováno v:
Advances in Chronic Kidney Disease. 21:456-459
Publikováno v:
Journal of Public Health. 37:3-5